Vetigenics
Business Services · Pennsylvania, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Lab 2929 Arch St Fl 4 436, Philadelphia,...Website
www.vetigenics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Vetigenics
Vetigenics was founded in 2017 through a National Cancer Institute (NCI) small business innovation research award to create fully canine research antibodies to support the field of comparative oncology. The companys mission has evolved to transform personalized healthcare for pets while driving advancements in human medicine. The company's state-of-the-art phage display platform enables the company to rapidly produce entirely canine antibodies or CANIBODIES that are the building blocks for monoclonal and bispecific antibodies, CAR T-cells, and more. The company's novel technology has successfully generated antibodies for both dogs and cats across a wide range of therapeutic areas. Vetigenics remains committed to the field of comparative oncology and has created a path to enable pets and their humans to live their best lives.Explore more
Vetigenics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vetigenics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Vetigenics
Click to see if Vetigenics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Vetigenics has new funding data
Check out if Vetigenics is spiking on competitors!
Check if Vetigenics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Vetigenics recently announced quarterly report
Product Launch: Get notified when Vetigenics launches new products
Vetigenics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Vetigenics
Compare insights from companies similar to Vetigenics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vetigenics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Vetigenics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Vetigenics.
Vetigenics financials insights
Gather financial insights about Vetigenics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Angel/Seed
$6M
Vetigenics Tech Stack
A closer look at the technologies used by Vetigenics
Vetigenics News & Media
Biotechnology company announces financial and clinical milestones
Vetigenics is seeing encouraging results of a completed study for an antibody aimed at treating oral melanoma in dogs, used in combination with palliative radition.Vetigenics secures $6 million seed financing, sees meaningful clinical progress
Pet biotech establishes board of directors, looks ahead to therapies for autoimmune disease, obesity and allergy. PHILADELPHIA, Feb. 3, 2025 /PRNewswire/ -- Vetigenics, a clinical-stage animal health biotechnology company specializing in antibody therapeutics for pets, announces...First canine patient receives Vetigenics' fully canine anti-CTLA4 monoclonal antibody for oral melanoma
Two fully funded pilot studies to treat cancer free for pet owners who bring their dogs to research sites. PHILADELPHIA, Nov. 2, 2023 /PRNewswire/ -- Vetigenics, a clinical-stage biopharmaceutical company advancing antibody-based therapies for pets, announces that the first canine patient...VETIGENICS ANNOUNCES SECOND DISCOVERY COLLABORATION WITH A MAJOR ANIMAL HEALTH PHARMA
New partnership established to explore multiple novel therapeutic antibodies for treating challenging pet diseases. PHILADELPHIA, Nov. 8, 2022 /PRNewswire/ -- Vetigenics, an animal health biotechnology company, today announced a second discovery collaboration with a major animal health...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vetigenics
Sign Up For FreeTo access detailed company insights
Vetigenics was founded in 2017 through a National Cancer Institute (NCI) small business innovation research award to create fully canine research antibodies to support the field of comparative oncology. The companys mission has evolved to transform personalized healthcare for pets while driving advancements in human medicine. The company's state-of... Read More
